News
The general manager of Bioiberica highlighted his companys commitment to a comprehensive approach to the treatment of osteoarthritis: prevention, chondroprotector drugs, and personalized medicine. Together, all these elements improve the patients quality of life.
The La mañana de la 1 program, broadcast by Televisión Española (TVE), devoted its saber vivir health section to the treatment of osteoarthritis.
Bioibérica Farma, the only Spanish company specializing in the treatment of osteoarthritis, launches an osteoarthritis awareness campaign. According to the World Health Organization (WHO), osteoarthritis is the fourth most common cause of loss of Quality Adjusted Life Years.
Dr. Cristóbal Orellana, Associate Physician at the Service of Rheumatology of the Parc Taulí Hospital (Sabadell, Barcelona) commented that biomarkers extracted from type II collagen, a type of collagen that can be found only in the cartilage, holds great promise for diagnosing osteoarthritis, and for monitoring its treatment.